NO2222330T3 - - Google Patents
Info
- Publication number
- NO2222330T3 NO2222330T3 NO08863153A NO08863153A NO2222330T3 NO 2222330 T3 NO2222330 T3 NO 2222330T3 NO 08863153 A NO08863153 A NO 08863153A NO 08863153 A NO08863153 A NO 08863153A NO 2222330 T3 NO2222330 T3 NO 2222330T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0205807A AT506258A1 (de) | 2007-12-18 | 2007-12-18 | Behandlung inflammatorischer krankheiten |
| PCT/AT2008/000460 WO2009076694A1 (fr) | 2007-12-18 | 2008-12-18 | Traitement de maladies inflammatoires par ace2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2222330T3 true NO2222330T3 (fr) | 2018-03-10 |
Family
ID=40467374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO08863153A NO2222330T3 (fr) | 2007-12-18 | 2008-12-18 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9561263B2 (fr) |
| EP (2) | EP2222330B1 (fr) |
| JP (3) | JP5755448B2 (fr) |
| AT (1) | AT506258A1 (fr) |
| AU (1) | AU2008338288B2 (fr) |
| CA (1) | CA2709555C (fr) |
| DK (1) | DK2222330T3 (fr) |
| ES (1) | ES2650463T3 (fr) |
| NO (1) | NO2222330T3 (fr) |
| NZ (1) | NZ586228A (fr) |
| PL (1) | PL2222330T3 (fr) |
| PT (1) | PT2222330T (fr) |
| WO (1) | WO2009076694A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT505262A1 (de) * | 2007-06-12 | 2008-12-15 | Apeiron Biolog Forschungs Und | Rekombinantes ace2 polypeptid |
| EP2077119A1 (fr) * | 2007-12-21 | 2009-07-08 | Apeiron Biologics Forschungs- und Entwicklungsgesellschaft M.B.H. | Traitement de fibroses et de maladies du foie |
| US8557958B1 (en) | 2012-06-18 | 2013-10-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of diabetes |
| US8633158B1 (en) | 2012-10-02 | 2014-01-21 | Tarix Pharmaceuticals Ltd. | Angiotensin in treating brain conditions |
| US9333233B2 (en) | 2014-02-25 | 2016-05-10 | Tarix Pharmaceuticals Ltd. | Methods and compositions for the delayed treatment of stroke |
| EP3574094A4 (fr) | 2017-01-24 | 2020-11-11 | Northwestern University | Variants actifs de bas poids moléculaire de l'enzyme de conversion de l'angiotensine ii (eca ii) |
| WO2021174107A2 (fr) * | 2020-02-26 | 2021-09-02 | Northwestern University | Variants d'ace2 solubles et utilisations associées |
| WO2021190980A1 (fr) | 2020-03-22 | 2021-09-30 | Quadrucept Bio Limited | Multimères pour l'évolution d'une souche virale |
| US12194157B2 (en) | 2020-04-09 | 2025-01-14 | Finncure Oy | Carrier for targeted delivery to a host |
| AU2021252164A1 (en) | 2020-04-09 | 2022-12-15 | Finncure Oy | Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses |
| EP3906946A1 (fr) | 2020-05-04 | 2021-11-10 | EK Biosciences GmbH | Vésicule antipathogène |
| US20210386837A1 (en) * | 2020-05-18 | 2021-12-16 | Northwestern University | Active low molecular weight variants of angiotensin converting enzyme 2 (ace2) for the treatment of diseases and conditions of the eye |
| BR112023009875A2 (pt) | 2020-11-23 | 2024-02-06 | Genentech Inc | Métodos para tratar um indivíduo com uma infecção por sars-cov-2, para reduzir a ligação de sars-cov-2 a uma célula, para diminuir a infecção por sars-cov-2 e para identificar um modulador, métodos de profilaxia, moduladores isolados, usos e antagonistas |
| WO2022184659A1 (fr) | 2021-03-01 | 2022-09-09 | Quadrucept Bio Limited | Domaines d'anticorps et multimères |
| US20250009853A1 (en) | 2021-12-03 | 2025-01-09 | Wisconsin Alumni Research Foundation | Mutant ace2 proteins and methods of using same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610497B1 (en) * | 1997-12-11 | 2003-08-26 | Millennium Pharmaceuticals, Inc. | Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor |
| US6989363B1 (en) | 1997-12-11 | 2006-01-24 | Millennium Pharmaceuticals, Inc. | Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor |
| WO2002039997A2 (fr) * | 2000-11-01 | 2002-05-23 | Millennium Pharmaceuticals, Inc. | Composes modulant ace-2 et procedes d'utilisation associes |
| US6900033B2 (en) * | 2001-06-04 | 2005-05-31 | Human Genome Sciences, Inc. | Methods and compositions for modulating ACE-2 activity |
| SI2332582T1 (sl) | 2002-06-19 | 2014-03-31 | Apeiron Biologics Ag | Aktivacija ACE2 za zdravljenje srčne, pljučne in ledvične bolezni in hipertenzije |
| EP1723962A1 (fr) * | 2005-05-19 | 2006-11-22 | IMBA-Institut für Molekulare Biotechnologie GmbH | Utilisation des inhibiteurs du système de rénine-angiotensine pour le traitement des lesions poumonaires. |
| US7842709B2 (en) * | 2006-09-08 | 2010-11-30 | Ore Pharmaceuticals Inc. | Method for treating inflammatory diseases of the digestive tract |
-
2007
- 2007-12-18 AT AT0205807A patent/AT506258A1/de not_active Application Discontinuation
-
2008
- 2008-12-18 PT PT88631536T patent/PT2222330T/pt unknown
- 2008-12-18 AU AU2008338288A patent/AU2008338288B2/en active Active
- 2008-12-18 NO NO08863153A patent/NO2222330T3/no unknown
- 2008-12-18 PL PL08863153T patent/PL2222330T3/pl unknown
- 2008-12-18 ES ES08863153.6T patent/ES2650463T3/es active Active
- 2008-12-18 NZ NZ586228A patent/NZ586228A/en unknown
- 2008-12-18 WO PCT/AT2008/000460 patent/WO2009076694A1/fr not_active Ceased
- 2008-12-18 US US12/808,818 patent/US9561263B2/en active Active
- 2008-12-18 JP JP2010538266A patent/JP5755448B2/ja active Active
- 2008-12-18 CA CA2709555A patent/CA2709555C/fr active Active
- 2008-12-18 DK DK08863153.6T patent/DK2222330T3/en active
- 2008-12-18 EP EP08863153.6A patent/EP2222330B1/fr active Active
- 2008-12-18 EP EP17178557.9A patent/EP3272357A1/fr not_active Withdrawn
-
2015
- 2015-02-09 JP JP2015022979A patent/JP6042919B2/ja active Active
-
2016
- 2016-11-10 JP JP2016219298A patent/JP2017061510A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017061510A (ja) | 2017-03-30 |
| CA2709555C (fr) | 2018-10-16 |
| US20110020315A1 (en) | 2011-01-27 |
| EP3272357A1 (fr) | 2018-01-24 |
| EP2222330B1 (fr) | 2017-10-11 |
| CA2709555A1 (fr) | 2009-06-25 |
| EP2222330A1 (fr) | 2010-09-01 |
| ES2650463T3 (es) | 2018-01-18 |
| WO2009076694A1 (fr) | 2009-06-25 |
| AT506258A1 (de) | 2009-07-15 |
| NZ586228A (en) | 2012-06-29 |
| JP5755448B2 (ja) | 2015-07-29 |
| AU2008338288B2 (en) | 2015-01-22 |
| DK2222330T3 (en) | 2017-12-11 |
| PL2222330T3 (pl) | 2018-03-30 |
| JP2011505842A (ja) | 2011-03-03 |
| PT2222330T (pt) | 2018-01-03 |
| JP6042919B2 (ja) | 2016-12-14 |
| US9561263B2 (en) | 2017-02-07 |
| AU2008338288A1 (en) | 2009-06-25 |
| JP2015145368A (ja) | 2015-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0819773A2 (fr) | ||
| CN300728875S (zh) | 椅子(38) | |
| CN300726997S (zh) | 集装箱 | |
| CN300729578S (zh) | 包装袋 | |
| CN300730157S (zh) | 风冷柴油机油箱装置 | |
| CN300728193S (zh) | 怀炉(1) | |
| CN300730988S (zh) | 宠物床(7) | |
| CN300727351S (zh) | 摩托车(426) | |
| CN300731140S (zh) | 手套(15) | |
| CN300728017S (zh) | 标识牌(2) | |
| CN300730360S (zh) | 店牌 | |
| CN300728926S (zh) | 桌子(6) | |
| CN300777603S (zh) | 床上用品套件(情迷唐古拉) | |
| CN300726337S (zh) | 班椅(oc-18) | |
| CN300816233S (zh) | 标贴(高效氟吡甲禾灵乳油) | |
| CN300728765S (zh) | 墙纸(15) | |
| CN300730745S (zh) | 舞台灯具(变焦成像灯) | |
| CN300728436S (zh) | 射灯(led-k) | |
| CN300730808S (zh) | 蜡烛(72) | |
| CN300779679S (zh) | 路灯灯具(神州一号) | |
| CN300728763S (zh) | 墙纸(18) | |
| CN300781854S (zh) | 涨紧轮(jx8230) | |
| CN300726202S (zh) | 布(7) | |
| CN300811665S (zh) | 长桌(azg-0068) | |
| CN300728462S (zh) | 烟灰缸(3012) |